Follow today's market news in real time: CAC 40 prices, corporate announcements, financial releases and market information. This page automatically aggregates the latest briefs and press releases to give you the most up-to-date view of the moves driving the session.
The recycling and community services specialist shows a weekly performance significantly better than that of the Parisian indices.
DBV Technologies closed the week at €2.59, marking a significant increase of 33.51% over five sessions, contrasting with declines in the CAC 40 and SBF 120 of 1…
The stock of the Dijon-based pharmaceutical company closed on Friday at €2.3250, showing significant progress in a generally downward-trending Parisian market.
The biotechnology company's stock ended the week at €3.60, up from €2.995 on Monday, marking a 20.2% increase over five trading days. This surge starkly contras…
Azelis Group's stock closed the week at €10.82, marking a sharp decline of 9.15% from the previous Friday. This weekly correction is part of a broader downward …
Atos shares ended the week at €54.04, down 11.48% from the previous week's close. This decline contrasts with the performance of the CAC 40 and the SBF 120, whi…
The French biotech is among the top gainers on the Paris stock exchange at the start of the session, driven by a spectacular momentum that has been building for…
Shares of the electro-optical technology specialist opened up 6.9% on Monday, October 13, at 46.45 euros. This increase is part of a sustained upward trend, wit…
The stock showed a significant increase of 7.21% this Monday morning at the opening, bringing the price to 84.80 euros from 79.10 euros the previous day. This r…
The biotech company from Montpellier shows a marked increase at the opening this Monday morning, driven by a US regulatory announcement made last Friday evening…
The stock of the French chemical company experienced a significant correction during the last five trading sessions, closing on Friday at 49.74 euros.
Alfen, a Dutch energy solutions specialist, saw its stock close at €10.54 on Friday, up 9.17% from the previous Monday, outperforming the general market trend.
The Lyon-based company specializing in diabetes and obesity treatments experienced a particularly dynamic week, closing at €9.75 on Friday, October 10. This wee…
DISCLAIMER: This information is not contractual in nature and carries no guarantee of accuracy. It should not be considered investment advice. Ideal-investisseur.fr cannot be held liable for any damages or losses arising from the use of this information.
